D.E. Shaw & Co
IMGO

D.E. Shaw & Co’s Imago BioSciences, Inc. Common stock IMGO Stock Holding History

D.E. Shaw & Co’s Portfolio IMGO Stock Details IMGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-32,058
Closed -$760K – 6159
2021
Q4 		$760K Buy
+32,058
New +$743K ﹤0.01% 4139

Other funds holding IMGO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

D.E. Shaw & Co's IMGO Position: Q1 2022 in Review

D.E. Shaw & Co sold out of Imago BioSciences, Inc. Common stock (IMGO) in Q1 2022, closing a stake of 32,058 shares — an estimated $760K sold.

D.E. Shaw & Co first reported a position in IMGO in Q4 2021 and held it in 1 quarter. The position peaked at $760K in Q4 2021. 59 funds tracked by Wall St. Rank hold IMGO as of Q1 2022.

  • D.E. Shaw & Co reported no remaining Imago BioSciences, Inc. Common stock position as of Q1 2022 after selling out during the quarter.
  • D.E. Shaw & Co sold 32,058 Imago BioSciences, Inc. Common stock shares in Q1 2022, an estimated $760K.
  • D.E. Shaw & Co first reported a position in Imago BioSciences, Inc. Common stock in Q4 2021 and held it in 1 quarter.
  • D.E. Shaw & Co's Imago BioSciences, Inc. Common stock position peaked at $760K in Q4 2021.
  • 59 funds tracked by Wall St. Rank held Imago BioSciences, Inc. Common stock as of Q1 2022.

Based on D.E. Shaw & Co's 13F filing for Q1 2022, filed 16 May 2022.